Ana Garcia Garcia de Paredes, Nicolo Manicardi, Luis Tellez, Luis Ibañez, Felix Royo, Javier Bermejo, Carolina Blanco, Constantino Fondevila, Val Fernandez Lanza, Laura Garcia-Bermejo, Juan Manuel Falcon-Perez, Rafael Bañares, Jordi Gracia-Sancho, Agustin Albillos
Noninvasive staging of decompensated cirrhosis is an unmet clinical need. The aims of this study were to characterize and validate a novel microRNA (miRNA) signature to stage decompensated cirrhosis and predict the portal pressure and systolic cardiac response to nonselective beta-blockers (NSBBs). Serum samples from patients with decompensated cirrhosis (n = 36) and healthy controls (n = 36) were tested for a novel signature of five miRNAs (miR-452-5p, miR-429, miR-885-5p, miR-181b-5p, and miR-122-5p) identified in the secretome of primary human hepatocytes and for three miRNAs (miR-192-5p, miR-34a-5p, and miR-29a-5p) previously discovered as biomarkers of chronic liver disease...
February 2021: Hepatology Communications